Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.
Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.
أغلقت الصفقة: تم الوصول للهدف
